Emilie Ceraudo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emilie Ceraudo has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Thomas P. Sakmar
Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University
21 shared publications - Yu Chen
Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
11 shared publications - Amanda R. Moore
Department of Research Oncology, Genentech, South San Francisco, USA
10 shared publications - Ping Chi
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
10 shared publications - Thomas Huber
Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University
10 shared publications - Tyler D. Hitchman
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
10 shared publications
Latest Publications
- 17 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 17 (854) , eadp3967
The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence
In contrast with sun exposure–induced melanoma, rarer melanocytic tumors and neoplasms with low mutational burden present opportunities to study isolated signaling mechanisms. These include uveal melanoma and blue nevi, which are often driven by mutations within the G protein–coupled signaling cascade downstream of cysteinyl leukotriene receptor 2. Here, we review how the same mutations within this pathway drive the growth of melanocytes in one tissue but can inhibit the growth of those in another, exemplifying the role of the tissue environment in the delicate balance between uncontrolled cell growth and senescence.
- 17 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 17 (854) , eadp3967
The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence
In contrast with sun exposure–induced melanoma, rarer melanocytic tumors and neoplasms with low mutational burden present opportunities to study isolated signaling mechanisms. These include uveal melanoma and blue nevi, which are often driven by mutations within the G protein–coupled signaling cascade downstream of cysteinyl leukotriene receptor 2. Here, we review how the same mutations within this pathway drive the growth of melanocytes in one tissue but can inhibit the growth of those in another, exemplifying the role of the tissue environment in the delicate balance between uncontrolled cell growth and senescence.
- Open Access
- 2 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (31) , eado9959
Multiplexed mapping of the interactome of GPCRs with receptor activity–modifying proteins
Receptor activity–modifying proteins (RAMPs) form complexes with G protein–coupled receptors (GPCRs) and may regulate their cellular trafficking and pharmacology. RAMP interactions have been identified for about 50 GPCRs, but only a few GPCR-RAMP complexes have been studied in detail. To elucidate a comprehensive GPCR-RAMP interactome, we created a library of 215 dual epitope-tagged (DuET) GPCRs representing all GPCR subfamilies and coexpressed each GPCR with each of the three RAMPs. Screening the GPCR-RAMP pairs with customized multiplexed suspension bead array (SBA) immunoassays, we identified 122 GPCRs that showed strong evidence for interaction with at least one RAMP. We screened for interactions in three cell lines and found 23 endogenously expressed GPCRs that formed complexes with RAMPs. Mapping the GPCR-RAMP interactome expands the current system-wide functional characterization of RAMP-interacting GPCRs to inform the design of selective therapeutics targeting GPCR-RAMP complexes.
- 2 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (31) , eado9959
Open AccessMultiplexed mapping of the interactome of GPCRs with receptor activity–modifying proteins
Receptor activity–modifying proteins (RAMPs) form complexes with G protein–coupled receptors (GPCRs) and may regulate their cellular trafficking and pharmacology. RAMP interactions have been identified for about 50 GPCRs, but only a few GPCR-RAMP complexes have been studied in detail. To elucidate a comprehensive GPCR-RAMP interactome, we created a library of 215 dual epitope-tagged (DuET) GPCRs representing all GPCR subfamilies and coexpressed each GPCR with each of the three RAMPs. Screening the GPCR-RAMP pairs with customized multiplexed suspension bead array (SBA) immunoassays, we identified 122 GPCRs that showed strong evidence for interaction with at least one RAMP. We screened for interactions in three cell lines and found 23 endogenously expressed GPCRs that formed complexes with RAMPs. Mapping the GPCR-RAMP interactome expands the current system-wide functional characterization of RAMP-interacting GPCRs to inform the design of selective therapeutics targeting GPCR-RAMP complexes.
- Open Access
Expanding the GPCR-RAMP interactome
Receptor activity-modifying proteins (RAMPs) can form complexes with G protein-coupled receptors (GPCRs) and regulate their cellular trafficking and pharmacology. RAMP interactions have been identified for about 50 GPCRs, but only a few GPCR-RAMP complexes have been studied in detail. To elucidate a complete interactome between GPCRs and the three RAMPs, we developed a customized library of 215 Dual Epitope-Tagged (DuET) GPCRs representing all GPCR subfamilies. Using a multiplexed suspension bead array (SBA) assay, we identified 122 GPCRs that showed strong evidence for interaction with at least one RAMP. We screened for native interactions in three cell lines and found 23 GPCRs that formed complexes with RAMPs. Mapping the GPCR-RAMP interactome expands the current system-wide functional characterization of RAMP-interacting GPCRs to inform the design of selective GPCR-targeted therapeutics. One-Sentence Summary: Novel complexes between G protein-coupled receptors and interacting proteins point to a system-wide regulation of GPCR function.
Open AccessExpanding the GPCR-RAMP interactome
Receptor activity-modifying proteins (RAMPs) can form complexes with G protein-coupled receptors (GPCRs) and regulate their cellular trafficking and pharmacology. RAMP interactions have been identified for about 50 GPCRs, but only a few GPCR-RAMP complexes have been studied in detail. To elucidate a complete interactome between GPCRs and the three RAMPs, we developed a customized library of 215 Dual Epitope-Tagged (DuET) GPCRs representing all GPCR subfamilies. Using a multiplexed suspension bead array (SBA) assay, we identified 122 GPCRs that showed strong evidence for interaction with at least one RAMP. We screened for native interactions in three cell lines and found 23 GPCRs that formed complexes with RAMPs. Mapping the GPCR-RAMP interactome expands the current system-wide functional characterization of RAMP-interacting GPCRs to inform the design of selective GPCR-targeted therapeutics. One-Sentence Summary: Novel complexes between G protein-coupled receptors and interacting proteins point to a system-wide regulation of GPCR function.
- Open Access
- 20 October 2023
- Published by Elsevier in Analytical Biochemistry
- Vol. 684, 115361
Application of bioluminescence resonance energy transfer to quantitate cell-surface expression of membrane proteins
- 20 October 2023
- Published by Elsevier in Analytical Biochemistry
- Vol. 684, 115361
Open AccessApplication of bioluminescence resonance energy transfer to quantitate cell-surface expression of membrane proteins
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S6 from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Supplementary figures S1-S6 with figure legends.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S6 from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Supplementary figures S1-S6 with figure legends.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma